To access this element change to forms mode OFF
Grant Award View - GA187497
Defining NF1 clinical variation at the microscale to discover new...
GA ID:
GA187497
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
31-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-May-2024
Value (AUD):
$818,472.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
MRFF_2020_Neurofibromatosis_Research_2021
Grant Activity:
Defining NF1 clinical variation at the microscale to discover new therapeutic targets
Purpose:
Treatment of neurofibromatosis type 1 remains a significant challenge. Patients are diagnosed by detecting loss or changes in the neurofibromin gene. However, this genetic information is not enough to predict disease severity. We will apply new technologies to uncover how the neurofibromin protein is dysregulated at the atomic level and inside the cell. This project will enhance our ability to predict disease severity at diagnosis and discover new pathways for therapeutic intervention.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2020 Neurofibromatosis Research Grant Opportunity
Internal Reference ID:
MRF2010629
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA